Artigo Revisado por pares

Predicting the treatment outcome of nivolumab in recurrent or metastatic head and neck squamous cell carcinoma: prognostic value of combined performance status and modified Glasgow prognostic score

2020; Springer Science+Business Media; Volume: 277; Issue: 8 Linguagem: Inglês

10.1007/s00405-020-05945-5

ISSN

1434-4726

Autores

Yushi Ueki, Takeshi Takahashi, Hisayuki Ota, Ryusuke Shodo, Keisuke Yamazaki, Arata Horii,

Tópico(s)

Head and Neck Cancer Studies

Referência(s)